163 related articles for article (PubMed ID: 26123465)
1. Intrapleural cisplatin for management of malignant pleural effusion in a patient with plasma cell leucaemia.
Agarwal A; Klair J; Patolia S; Meena NK
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123465
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection.
Congcong Q; Hengting Z; Shuhui L; Fang Y; Shan W
Am J Med Sci; 2019 Dec; 358(6):400-411. PubMed ID: 31813467
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
[TBL] [Abstract][Full Text] [Related]
5. Pleural Effusion in Multiple Myeloma.
Wang Z; Xia G; Lan L; Liu F; Wang Y; Liu B; Ding Y; Dai L; Zhang Y
Intern Med; 2016; 55(4):339-45. PubMed ID: 26875957
[TBL] [Abstract][Full Text] [Related]
6. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma with myelomatous pleural effusion: a case report and review of the literature.
Kim YJ; Kim SJ; Min K; Kim HY; Kim HJ; Lee YK; Zang DY
Acta Haematol; 2008; 120(2):108-11. PubMed ID: 18957845
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion.
Shoji T; Tanaka F; Yanagihara K; Inui K; Wada H
Chest; 2002 Mar; 121(3):821-4. PubMed ID: 11888966
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion.
Jones DR; Taylor MD; Petroni GR; Shu J; Burks SG; Daniel TM; Gillenwater HH
J Thorac Oncol; 2010 Jan; 5(1):75-81. PubMed ID: 19884858
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
Kang M; Zhou L; Lin P
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of elemene versus DDP intrapleural injection in the treatment of malignant pleural effusion caused by lung cancer.
Wang X; Wang H; Li L
J Cancer Res Ther; 2016 Dec; 12(Supplement):C244-C247. PubMed ID: 28230027
[TBL] [Abstract][Full Text] [Related]
14. Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?
Chen D; Song X; Wang H; Gao Z; Meng W; Chen S; Ma Y; Wang Y; Li K; Yu J; Yue J
Front Immunol; 2018; 9():2916. PubMed ID: 30619280
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P
Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613
[TBL] [Abstract][Full Text] [Related]
16. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
SHI Z; HE QY; HUA BJ
Chin J Integr Med; 2008 Dec; 14(4):257-61. PubMed ID: 19082796
[TBL] [Abstract][Full Text] [Related]
17. [The intrapleural administration of platidiam (cisplatin) in treating specific pleurisy in malignant neoplasms].
Voznyĭ EK; Meshcheriakova NG
Vopr Onkol; 1992; 38(10):1249-53. PubMed ID: 1343153
[No Abstract] [Full Text] [Related]
18. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer.
Orlandi E; Mordenti P; Zangrandi A; Cavanna L
Chemotherapy; 2014; 60(5-6):321-4. PubMed ID: 26279275
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
